Magnolia Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
ATO
Magnolia Capital Management's MRK Position: Q2 2026 in Review
Magnolia Capital Management reduced its Merck (MRK) stake by 25% in Q2 2026, selling an estimated $325K and leaving 8,417 shares worth $1.08M. The position accounts for 0.75% of the portfolio, ranked #23.
Magnolia Capital Management first reported a position in MRK in Q4 2019 and has held it in 21 quarters since. The position peaked at $1.35M in Q1 2026. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Magnolia Capital Management held 8,417 shares of Merck worth $1.08M as of Q2 2026.
- Magnolia Capital Management sold 2,779 Merck shares in Q2 2026, an estimated $325K.
- Merck made up 0.75% of Magnolia Capital Management's portfolio in Q2 2026, its #23 holding.
- Magnolia Capital Management first reported a position in Merck in Q4 2019 and has held it in 21 quarters since.
- Magnolia Capital Management's Merck position peaked at $1.35M in Q1 2026.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Magnolia Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.